HGG-36. HIF-2: A NEW DRUG TARGET IN PEDIATRIC HIGH-GRADE GLIOMA WITH PROMISING PRECLINICAL RESULTS

Pediatric high-grade gliomas (pHGGs) have a very dismal prognosis and need new innovative strategy for treatment. Despite the past discovery of histone H3 driver mutations, we are not able for instance to stop this induced epigenetic remodulation. Therefore, proactive translational studies wish to g...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Fuchs, Quentin, Pierrevelcin, Marina, Papin, Christophe, Dontenwill, Monique, Entz-Werlé, Natacha
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
High Grade Glioma
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715113/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.317
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky